There is nothing wrong in stating that the AD trial has been completed. The market will decide if this is big news, given that this is AD. It has been a long time since the trials started and may be the market needs to be reminded.
Not that Anavex should emulate other companies, but SAVA and ANVS did just that if I am not mistaken.